Cargando…

Pharmaceutical companies as the funding sources for continuing medical education

Detalles Bibliográficos
Autor principal:	Kanchan, Tanuj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366922/ https://www.ncbi.nlm.nih.gov/pubmed/25810619 http://dx.doi.org/10.4103/0972-5229.152778

Ejemplares similares

Funding sources for continuing medical education: A different perspective
por: Walsh, Kieran
Publicado: (2014)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Funding sources for continuing medical education: An observational study
por: Venkataraman, Ramesh, et al.
Publicado: (2014)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Continuing Medical Education
por: Dunstan, Edmund
Publicado: (1998)

Preferred Methods of Suicide and Most Common Poisonings in India
por: Kanchan, Tanuj
Publicado: (2014)

Measurement Error in Anthropometric Studies and its Significance in Forensic Casework
por: Krishan, Kewal, et al.
Publicado: (2016)

Journal impact factor – Handle with care
por: Kanchan, Tanuj, et al.
Publicado: (2016)

Intrauterine vertical transmissibility of severe acute respiratory syndrome coronavirus 2: did we just miss the proof?
por: Jain, Vidhi, et al.
Publicado: (2020)

Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies
por: Murayama, Anju, et al.
Publicado: (2021)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Continuing medical education (CME): Why the fuss?
por: Sohoni, Chandrashekhar
Publicado: (2011)

Webinar: the New Way of Continued Medical Education
por: Biradar, Amaresh
Publicado: (2020)

Who Will Fund Postgraduate Education after 1992?
por: Saunders, K. B.
Publicado: (1991)

Post-mortem ultrasonography: a safer alternative to autopsies in COVID-19 deaths
por: Kanchan, Tanuj, et al.
Publicado: (2020)

Perils of human remains examination in COVID-19 times
por: Parekh, Utsav, et al.
Publicado: (2021)

Re: Teenage Pregnancies in Nepal - The Problem Status and Socio-Legal Concerns – Letter to The Editor
por: Nepal, Samata, et al.
Publicado: (2019)

Webinar as Future of Continued Medical Education: a Survey
por: Verma, Anjali, et al.
Publicado: (2021)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successes
por: Hayes, Ann G., et al.
Publicado: (2019)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Continuing Medical Education Outcomes are Much More Than Statistical Significance
por: Lucero, Katie Stringer, et al.
Publicado: (2023)

The British Medical Benevolent Fund
por: Haynes, Horace
Publicado: (1901)

The "Royal" Medical Benevolent Fund
por: West, Samuel
Publicado: (1912)

From Students to Educators: Peer-assisted Strategies for Continued Medical Education during the COVID-19 Pandemic
por: Punjabi, Lavisha S.
Publicado: (2021)

Patient Organizations’ Funding from Pharmaceutical Companies: Is Disclosure Clear, Complete and Accessible to the Public? An Italian Survey
por: Colombo, Cinzia, et al.
Publicado: (2012)

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005)

Gender and racial bias in drug promotional material distributed by pharmaceutical companies
por: Jaykaran,, et al.
Publicado: (2012)

The British Medical Benevolent Fund and Guild
por: Bedford, Adeline M., et al.
Publicado: (1910)

Continuous Medical Education Changes Practice: One Year After SMART and SALT-ED
por: Siuba, Matthew T., et al.
Publicado: (2019)

Venture capital funding of dermatology companies founded by women: a unique set of challenges
por: Desai, Amar D., et al.
Publicado: (2023)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Is it possible to align the teaching of radiology in undergraduate medicine with that employed in graduate and continuing medical education courses?
por: da Silva, Alexandre Ferreira
Publicado: (2018)

National Insurance: The Distribution of the Medical Benefit Fund
por: Thyne, John Tod
Publicado: (1913)

Tobacco companies are booming despite an economic depression
por: He, Peisen, et al.
Publicado: (2009)

Fund Raising for the Uninitiated
por: Wicks, A C B, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_j7oq7bs6l1lah0jaemojhvfjur